Skip to main content
Clinical Trials/NCT03861650
NCT03861650CompletedNot Applicable

The Effect of Bone Marrow Aspirate Concentrate on Bone Regenerate During Rapid Mandibular Distraction Osteogensis

Yasser Mohamed Nabil Ahmed Khirat El Hadidi0 sites12 target enrollmentStarted: December 30, 2015Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
12
Primary Endpoint
Assessment of effect of BMAC on rapidly distracted bone quality

Study Overview

Brief Summary

Maxillofacial Distraction Osteogenesis (DO) has a lot of draw backs; mostly related to long distraction and consolidation time. Rapid rate DO was proposed to decrease the distraction time to avoid consequences of long procedure. The idea of the current study is to provide mesenchymal stem cells (MSCs) in form of Bone Marrow Aspirate Concentrate (BMAC) during rapid distraction to fasten and shorten consolidation. Methods: This trial was conducted on patients requiring mandibular DO. Patients were divided in two groups; control group in which distraction took place at a rate of 1.5 mm /day without any enhancement and study group in which distraction took place at rate of 1.5 mm /day and the distracted bone was enhanced by BMAC

Detailed Description

Material and Methods:

A prospective case-control trial was conducted on patients requiring mandibular distraction osteogenesis to assess the effect of BMAC on distracted bone quality. Evaluation of newly formed bone quantity and quality was done using a CBCT which was done post distractor removal as a part of routine follow up ( in agreement with European guidelines for the exposure to ionizing radiation) and evaluation of the bone quality was assessed by two examiners to provide interexaminer-reliability.

In order to evaluate the effect of BMAC on bone maturation and possibility of early removal of the distractor; which was not feasible in the clinical study due to the ethical concerns. Mechanical three point bending was applied on distracted mandible after 30 days following distraction to evaluate bone healing and mechanical strength of distracted bone. In addition to histological and radiographic evaluation.

Patients and methods:

Patient grouping and anesthetic technique:

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Care Provider)

Masking Description

Single blinded

Eligibility Criteria

Ages
6 Years to 25 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients free from any disease affecting bone formation of both sexes was included in the study.
  • Patients younger than 25 years old.
  • Patients included in the study were post traumatic patients, hemifacial microsomia, Treacher Collins and post ankylotic mandibular deformity.
  • Distraction range was between 15-20 mm.

Exclusion Criteria

  • The presence of uncontrolled systemic disease.
  • Previous radiotherapy on head and neck region.
  • Chemotherapy within the past 12-month period.
  • An active infection at the distraction site.

Arms & Interventions

Saline

Sham Comparator

Sham or placebo drug in the control group

Intervention: Saline (Other)

Bone Marrow Aspirate Concentrate

Experimental

Bone Marrow Aspirate Concentrate is prepared from bone marrow by aspiration by wide bore needle and then prepared by centrifugation to get rich mix of MSCs to improve healing

Intervention: Bone Marrow Aspirate Concentrate (Other)

Outcomes

Primary Outcomes

Assessment of effect of BMAC on rapidly distracted bone quality

Time Frame: 6 months

radiographically the bone density was assessed using CBCT of the patients to evaluate the effect of BMAC on bone maturation in term of increased bone density measured in Hounsfield unit as the increase in bone density indicates better healing and more bone maturation and justify addition of BMAC

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Yasser Mohamed Nabil Ahmed Khirat El Hadidi
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Yasser Mohamed Nabil Ahmed Khirat El Hadidi

Assistant Lecturer

Ain Shams University

Similar Trials